Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States

By sjmartinez • February 11, 2023

Tenforde MW, Self WH, Zhu Y, Naioti EA, Gaglani M, Ginde AA, Jensen K, Talbot HK, Casey JD, Mohr NM, Zepeski A, McNeal T, Ghamande S, Gibbs KW, Files DC, Hager DN, Shehu A, Prekker ME, Erickson HL, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Peltan ID, Brown SM, Martin ET, Monto AS, Khan A, Hough CL, Busse LW, Lohuis CT, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Rivas C, Babcock HM, Kwon JH, Exline MC, Botros MM, Lauring AS, Shapiro NI, Halasa N, Chappell JD, Grijalva CG, Rice TW, Jones ID, Stubblefield WB, Baughman A, Womack KN, Rhoads JP, Lindsell CJ, Hart KW, Turbyfill C, Olson S, Murray N, Adams K, Patel MM; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. Clin Infect Dis. 2023 Feb 8;76(3):e460-e468. doi: 10.1093/cid/ciac381. PMID: 35580849; PMCID: PMC9129194.

Tags: covid-19, duration of protection, mRNA, Publications, Pulmonary, Critical Care & Sleep Medicine, vaccine effectiveness, waning

Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical Trial

Bishop CW, Ashfaq A, Choe J, Strugnell SA, Johnson LL, Norris KC, Sprague SM. Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism[...]

Social isolation and functional impairment trajectories in a diverse cohort of middle-aged and older adults in Northern California

Rojas-Saunero LP, Ikesu R, Zhou Y, Hayes-Larson E, Fong JO, Chen R, Posis AIB, Whitmer RA, Gilsanz P, Glymour MM, Torres JM, Kotwal AA, Mayeda[...]

Cognitive Function and Neurodegenerative Blood Biomarkers in an Aging Indian Population: Insights From LASI-DAD Wave 2

Rao AR, Pradhan R, Anwar M, Gupta A, Bhagwasia M, Nichols E, Gross AL, Thyagarajan B, Hu P, Crimmins EM, Dey AB, Lee J, Dey[...]